← All organizations

Foundation to Eradicate Duchenne

Academic/Hospital

Also known as: Foundation to Eradicate Duchenne

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 31, 2019

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

canakinumab

Indications

Studied for

Recent trials (1)

NCT03936894CollaboratorPhase 1/Phase 2May 31, 2019

Details

Last known activity: May 31, 2019